Data Characteristics in This Category
Pharmacoeconomic data primarily originates from clinical trial reports, real-world evidence (RWE) studies, health insurance reimbursement policies, and post-market drug surveillance. Update frequencies vary. Clinical trial data typically releases after study completion. Market and policy data may update quarterly or annually. Document structures are mainly structured tabular data and unstructured text reports, such as cost-effectiveness analysis reports and budget impact analysis reports. Data fields include drug prices, treatment costs, disease burden, quality-adjusted life years (QALYs), and effectiveness indicators (e.g., PFS, OS). Units involve currency (e.g., USD, EUR), time (years, months), ratios, and unitless utility values.
Constraints Imposed by These Characteristics on "Workflow Orchestration"
The diversity of pharmacoeconomic data requires robust multi-source data integration capabilities within the workflow. Data from different sources and formats need standardization via pre-processing nodes. Examples include converting PDF clinical reports to parseable text or extracting specific metrics from Excel tables. Inconsistent data update cycles mean the workflow should support scheduled triggers and incremental update strategies to ensure real-time accuracy of pre-screening results. Furthermore, calculating specialized metrics like QALY and ICER (Incremental Cost-Effectiveness Ratio) often involves complex formulas and statistical models. This demands that processing nodes in the workflow can flexibly call external computing services or incorporate complex logical operations. The variance in field units necessitates strict unit validation and conversion during data input and output to prevent calculation errors due to unit mismatches.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 8000 Tokens | Processing pharmacoeconomic reports often requires understanding lengthy contexts to avoid missing critical information. |
Chunk size | 500 characters | Balances semantic completeness and segment recall efficiency, preventing long paragraphs from diluting key information. |
Similarity threshold | 0.75 | Pharmacoeconomic concepts and terminology are specialized. A higher threshold reduces recall of irrelevant information. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Parsing large clinical trial PDF files can be time-consuming. This allows sufficient time. |
Recall count | 10 entries | Ensures enough relevant evidence is retrieved during pre-screening to support subsequent economic evaluations. |
HTTP_REQUEST_TIMEOUT | 120 seconds | Prevents timeouts when calling external APIs for complex economic model calculations or data queries due to network latency. |
Three Common Mistakes
- When processing PDF reports, "processing failed" or "file content empty" errors frequently occur. This may be due to
PARSE_FILE_TIMEOUT_SECONDSbeing set too short, preventing large or complex PDF files from completing parsing within the allotted time. - Variables in
{{}}format are not parsed correctly when referenced in the workflow, leading to missing parameters in subsequent nodes. This typically results from using incompatible variable referencing in older versions or improper variable scope configuration. - The model's pre-screening output lacks critical economic indicator data. The model's response does not mention drug costs or QALYs. This can happen if these specific fields are filtered out or not correctly identified in the knowledge base's recalled raw data, preventing the model from accessing them for analysis.
How to Confirm Correct Configuration
- Upload a typical pharmacoeconomic report PDF containing key indicators like drug price and QALY. Observe parsing logs to confirm the file parsing status is "success" and indexed segment content includes core data.
- Execute a workflow that includes an external API call. Check if the
HTTP_REQUEST_TIMEOUTconfiguration successfully retrieves external calculation results and verify the returned data structure matches expectations. - For a typical clinical trial pre-screening scenario, run the workflow and examine the final output. Verify that the results include all expected economic evaluation elements, such as preliminary judgments on cost, benefit, and incremental cost-effectiveness ratio (ICER).
The values given are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.